|
1
|
Tian Y, Deng YB, Huang YJ and Wang Y: Bone
marrow-derived mesenchymal stem cells decrease acute
graft-versus-host disease after allogeneic hematopoietic stem cells
transplantation. Immunol Invest. 37:29–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Keyser KA, Beagles KE and Kiem HP:
Comparison of mesenchymal stem cells from different tissues to
suppress T-cell activation. Cell Transplant. 16:555–562. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sasaki M, Abe R, Fujita Y, Ando S, Inokuma
D and Shimizu H: Mesenchymal stem cells are recruited into wounded
skin and contribute to wound repair by transdifferentiation into
multiple skin cell type. J Immunol. 180:2581–2587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Colter DC, Class R, DiGirolamo CM and
Prockop DJ: Rapid expansion of recycling stem cells in cultures of
plastic-adherent cells from human bone marrow. Proc Natl Acad Sci
USA. 97:3213–3218. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sekiya I, Larson BL, Smith JR, Pochampally
R, Cui JG and Prockop DJ: Expansion of human adult stem cells from
bone marrow stroma: Conditions that maximize the yields of early
progenitors and evaluate their quality. Stem Cells. 20:530–541.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee RH, Hsu SC, Munoz J, Jung JS, Lee NR,
Pochampally R and Prockop DJ: A subset of human rapidly
self-renewing marrow stromal cells preferentially engraft in mice.
Blood. 107:2153–2161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Estrada JC, Torres Y, Benguría A, Dopazo
A, Roche E, Carrera-Quintanar L, Pérez RA, Enríquez JA, Torres R,
Ramírez JC, et al: Human mesenchymal stem cell-replicative
senescence and oxidative stress are closely linked to aneuploidy.
Cell Death Dis. 4:e6912013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wagner W, Horn P, Castoldi M, Diehlmann A,
Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, et al:
Replicative senescence of mesenchymal stem cells: A continuous and
organized process. PLoS One. 3:e22132008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schellenberg A, Lin Q, Schüler H, Koch CM,
Joussen S, Denecke B, Walenda G, Pallua N, Suschek CV, Zenke M, et
al: Replicative senescence of mesenchymal stem cells causes
DNA-methylation changes which correlate with repressive histone
marks. Aging (Albany NY). 3:873–888. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee RH, Seo MJ, Pulin AA, Gregory CA,
Ylostalo J and Prockop DJ: The CD34-like protein PODXL and
alpha6-integrin (CD49f) identify early progenitor MSCs with
increased clonogenicity and migration to infarcted heart in mice.
Blood. 113:816–826. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim DS, Lee MW, Yoo KH, Lee TH, Kim HJ,
Jang IK, Chun YH, Kim HJ, Park SJ, Lee SH, et al: Gene expression
profiles of human adipose tissue-derived mesenchymal stem cells are
modified by cell culture density. PLoS One. 9:e833632014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee MW, Kim DS, Yoo KH, Kim HR, Jang IK,
Lee JH, Kim SY, Son MH, Lee SH, Jung HL, et al: Human bone
marrow-derived mesenchymal stem cell gene expression patterns vary
with culture conditions. Blood Res. 48:107–114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: Implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jurgens WJ, Oedayrajsingh-Varma MJ, Helder
MN, Zandiehdoulabi B, Schouten TE, Kuik DJ, Ritt MJ and van
Milligen FJ: Effect of tissue-harvesting site on yield of stem
cells derived from adipose tissue: Implications for cell-based
therapies. Cell Tissue Res. 332:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee TH, Song SH, Kim KL, Yi JY, Shin GH,
Kim JY, Kim J, Han YM, Lee SH, Lee SH, et al: Functional
recapitulation of smooth muscle cells via induced pluripotent stem
cells from human aortic smooth muscle cells. Circ Res. 106:120–128.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martinez-Fernandez A, Nelson TJ, Yamada S,
Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y and Terzic A: iPS
programmed without c-MYC yield proficient cardiogenesis for
functional heart chimerism. Circ Res. 105:648–656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mauritz C, Schwanke K, Reppel M, Neef S,
Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler
J, et al: Generation of functional murine cardiac myocytes from
induced pluripotent stem cells. Circulation. 118:507–517. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang F, Citra F and Wang DA: Prospects of
induced pluripotent stem cell technology in regenerative medicine.
Tissue Eng Part B Rev. 17:115–124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu YH, Karra R and Wu SM: Cardiovascular
stem cells in regenerative medicine: Ready for prime time? Drug
Discov Today Ther Strateg. 5:201–207. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Uccelli A, Moretta L and Pistoia V:
Mesenchymal stem cells in health and disease. Nat Rev Immunol.
8:726–736. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Murphy MB, Moncivais K and Caplan AI:
Mesenchymal stem cells: Environmentally responsive therapeutics for
regenerative medicine. Exp Mol Med. 45:e542013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Melief SM, Zwaginga JJ, Fibbe WE and
Roelofs H: Adipose tissue-derived multipotent stromal cells have a
higher immunomodulatory capacity than their bone marrow-derived
counterparts. Stem Cells Transl Med. 2:455–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith JR, Pochampally R, Perry A, Hsu SC
and Prockop DJ: Isolation of a highly clonogenic and multipotential
subfraction of adult stem cells from bone marrow stroma. Stem
Cells. 22:823–831. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pricola KL, Kuhn NZ, Haleem-Smith H, Song
Y and Tuan RS: Interleukin-6 maintains bone marrow-derived
mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J
Cell Biochem. 108:577–588. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han SM, Han SH, Coh YR, Jang G, Ra J Chan,
Kang SK, Lee HW and Youn HY: Enhanced proliferation and
differentiation of Oct4- and Sox2-overexpressing human adipose
tissue mesenchymal stem cells. Exp Mol Med. 46:e1012014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Go MJ, Takenaka C and Ohgushi H: Forced
expression of Sox2 or Nanog in human bone marrow derived
mesenchymal stem cells maintains their expansion and
differentiation capabilities. Exp Cell Res. 314:1147–1154. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alison MR and Islam S: Attributes of adult
stem cells. J Pathol. 217:144–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iovino N and Cavalli G: Rolling ES cells
down the Waddington landscape with Oct4 and Sox2. Cell.
145:815–817. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu TM, Wu YN, Guo XM, Hui JH, Lee EH and
Lim B: Effects of ectopic Nanog and Oct4 overexpression on
mesenchymal stem cells. Stem Cells Dev. 18:1013–1022. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tondreau T, Meuleman N, Delforge A,
Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D and Lagneaux L:
Mesenchymal stem cells derived from CD133-positive cells in
mobilized peripheral blood and cord blood: Proliferation, Oct4
expression, and plasticity. Stem Cells. 23:1105–1112. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Greco SJ, Liu K and Rameshwar P:
Functional similarities among genes regulated by OCT4 in human
mesenchymal and embryonic stem cells. Stem Cells. 25:3143–3154.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsai CC, Su PF, Huang YF, Yew TL and Hung
SC: Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal
and undifferentiated state in mesenchymal stem cells. Mol Cell.
47:169–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Evans PM, Zhang W, Chen X, Yang J, Bhakat
KK and Liu C: Kruppel-like factor 4 is acetylated by p300 and
regulates gene transcription via modulation of histone acetylation.
J Biol Chem. 282:33994–34002. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Scheper W and Copray S: The molecular
mechanism of induced pluripotency: A two-stage switch. Stem Cell
Rev. 5:204–223. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Varlakhanova NV, Cotterman RF, deVries WN,
Morgan J, Donahue LR, Murray S, Knowles BB and Knoepfler PS: myc
maintains embryonic stem cell pluripotency and self-renewal.
Differentiation. 80:9–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kern S, Eichler H, Stoeve J, Klüter H and
Bieback K: Comparative analysis of mesenchymal stem cells from bone
marrow, umbilical cord blood, or adipose tissue. Stem Cells.
24:1294–1301. 2006. View Article : Google Scholar : PubMed/NCBI
|
